+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Acute Kidney Injury Clinical Trial Pipeline Highlights - 2022

  • PDF Icon

    Report

  • August 2022
  • Region: Global
  • Fore Pharma
  • ID: 5644754
The report Acute Kidney Injury Pipeline Highlights - 2022, provides the most up-to-date information on key pipeline products within the global Acute Kidney Injury market. It covers emerging therapies for Acute Kidney Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Acute Kidney Injury pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Acute Kidney Injury pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Acute Kidney Injury pipeline products by the company.

Short-term Launch Highlights:

Find out which Acute Kidney Injury pipeline products will be launched in the US and Ex-US till 2025.

SUMMARY:

  • Acute Kidney Injury phase 3 clinical trial pipeline products
  • Acute Kidney Injury phase 2 clinical trial pipeline products
  • Acute Kidney Injury phase 1 clinical trial pipeline products
  • Acute Kidney Injury preclinical research pipeline products
  • Acute Kidney Injury discovery stage pipeline products
  • Acute Kidney Injury pipeline products short-term launch highlights

Table of Contents

1. Acute Kidney Injury Pipeline by Stages
2. Acute Kidney Injury Phase 3 Clinical Trial Insights
3. Acute Kidney Injury Phase 2 Clinical Trial Insights
4. Acute Kidney Injury Phase 1 Clinical Trial Insights
5. Acute Kidney Injury Preclinical Research Insights
6. Acute Kidney Injury Discovery Stage Insights
7. Appendix
8. Research Methodology

List of Tables
Table 1: Acute Kidney Injury Phase 3 Clinical Trials, 2022
Table 2: Acute Kidney Injury Phase 2 Clinical Trials, 2022
Table 3: Acute Kidney Injury Phase 1 Clinical Trials, 2022
Table 4: Acute Kidney Injury Preclinical Research, 2022
Table 5: Acute Kidney Injury Discovery Stage, 2022

List of Figures
Figure 1: Acute Kidney Injury Pipeline Molecules by Clinical Trials Stage, 2022
Figure 2: Acute Kidney Injury Phase 3 Clinical Trial Highlights, 2022
Figure 3: Acute Kidney Injury Phase 2 Clinical Trial Highlights, 2022
Figure 4: Acute Kidney Injury Phase 1 Clinical Trial Highlights, 2022
Figure 5: Acute Kidney Injury Preclinical Research Highlights, 2022
Figure 6: Acute Kidney Injury Discovery Stage Highlights, 2022